Submitted URL: http://link.email.empr.com/a/1323/click/68057/5059933/951718768f6a199871913945f75629ecee39d166/bc6300650acbcf3b8ee719d2efc8...
Effective URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=emai...
Submission: On September 14 via api from US

Summary

This website contacted 46 IPs in 7 countries across 33 domains to perform 232 HTTP transactions. The main IP is 54.210.29.109, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.
This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
34 54.210.29.109 14618 (AMAZON-AES)
24 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
8 2a00:1450:400... 15169 (GOOGLE)
4 52.216.138.157 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:205... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
10 216.58.210.2 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 6 2a00:1450:400... 15169 (GOOGLE)
1 4 23.43.115.95 20940 (AKAMAI-ASN1)
5 2a00:1450:400... 15169 (GOOGLE)
66 2606:4700:20:... 13335 (CLOUDFLAR...)
1 18.213.112.55 14618 (AMAZON-AES)
1 13.35.253.71 16509 (AMAZON-02)
3 2a03:2880:f02... 32934 (FACEBOOK)
2 2 52.206.48.92 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 34.225.65.223 14618 (AMAZON-AES)
1 13.32.220.201 16509 (AMAZON-02)
4 52.3.171.116 14618 (AMAZON-AES)
2 8 52.31.106.135 16509 (AMAZON-02)
1 13.35.253.107 16509 (AMAZON-02)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 34.233.109.111 14618 (AMAZON-AES)
3 2a03:2880:f12... 32934 (FACEBOOK)
1 1 104.108.34.58 16625 (AKAMAI-AS)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.21.37.45 20940 (AKAMAI-ASN1)
2 2 18.200.54.67 16509 (AMAZON-02)
2 3 3.120.224.89 16509 (AMAZON-02)
2 35.227.192.113 15169 (GOOGLE)
4 3.209.234.104 14618 (AMAZON-AES)
4 34.197.62.58 14618 (AMAZON-AES)
2 143.204.214.69 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
4 2600:1f14:e96... 16509 (AMAZON-02)
4 2600:9000:205... 16509 (AMAZON-02)
2 4 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
2 54.149.252.201 16509 (AMAZON-02)
1 54.213.250.89 16509 (AMAZON-02)
1 54.194.238.142 16509 (AMAZON-02)
1 54.76.69.10 16509 (AMAZON-02)
1 2 2600:1f14:e96... 16509 (AMAZON-02)
1 54.213.66.127 16509 (AMAZON-02)
232 46
Apex Domain
Subdomains
Transfer
68 lytics.io
c.lytics.io
api.lytics.io
82 KB
35 empr.com
link.email.empr.com
www.empr.com
3 MB
24 netdna-ssl.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
236 KB
17 b2c.com
api.b2c.com
api-54-149-252-201.b2c.com
api-54-213-250-89.b2c.com
api-54-213-66-127.b2c.com
26 KB
11 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
101 KB
9 googlesyndication.com
tpc.googlesyndication.com Failed
pagead2.googlesyndication.com
204 KB
9 ml314.com
ml314.com
in.ml314.com
17 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
12 KB
6 spotible.com
ads.spotible.com
cdn1.spotible.com
709 KB
6 google-analytics.com
www.google-analytics.com
39 KB
5 gstatic.com
fonts.gstatic.com
65 KB
5 googletagservices.com
www.googletagservices.com
129 KB
4 medtargetsystem.com
www.medtargetsystem.com
53 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 amazonaws.com
s3.amazonaws.com
2 MB
4 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
13 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
245 B
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
119 KB
3 google.com
adservice.google.com
www.google.com
355 B
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
727 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
549 B
2 google.de
adservice.google.de
www.google.de
280 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 bluekai.com
tags.bluekai.com
856 B
1 alexametrics.com
certify.alexametrics.com
551 B
1 cloudfront.net
d31qbv1cthcecs.cloudfront.net
2 KB
1 crazyegg.com
script.crazyegg.com
28 KB
1 googletagmanager.com
www.googletagmanager.com
34 KB
232 33
Domain Requested by
66 c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
c.lytics.io
www.empr.com
34 www.empr.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.empr.com
8 ml314.com 2 redirects www.empr.com
ml314.com
6 api-54-149-252-201.b2c.com 2 redirects www.empr.com
6 tpc.googlesyndication.com securepubads.g.doubleclick.net
6 www.google-analytics.com 1 redirects www.googletagmanager.com
www.google-analytics.com
5 fonts.gstatic.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
5 www.googletagservices.com www.empr.com
securepubads.g.doubleclick.net
4 api-54-213-250-89.b2c.com 1 redirects www.empr.com
4 adtrackapi.haymarketmedia.com s3.amazonaws.com
4 api.b2c.com securepubads.g.doubleclick.net
www.empr.com
4 ads.spotible.com www.empr.com
ads.spotible.com
4 subapi.haymarketmedia.com s3.amazonaws.com
4 www.medtargetsystem.com www.empr.com
www.medtargetsystem.com
4 sb.scorecardresearch.com 1 redirects www.empr.com
www.googletagmanager.com
4 s3.amazonaws.com www.empr.com
3 api-54-213-66-127.b2c.com 1 redirects
3 pagead2.googlesyndication.com www.empr.com
3 ps.eyeota.net 2 redirects www.empr.com
3 www.facebook.com www.empr.com
connect.facebook.net
3 connect.facebook.net www.empr.com
connect.facebook.net
3 fonts.googleapis.com www.empr.com
s3.amazonaws.com
2 cdn1.spotible.com www.empr.com
2 api.lytics.io c.lytics.io
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 www.google.com 1 redirects securepubads.g.doubleclick.net
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 bcp.crwdcntrl.net tags.crwdcntrl.net
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 www.google.de www.empr.com
1 stats.g.doubleclick.net 1 redirects
1 certify.alexametrics.com www.empr.com
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.empr.com
1 d31qbv1cthcecs.cloudfront.net www.empr.com
1 accounts.haymarketmedia.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 content.maropost.com www.empr.com
1 www.googletagmanager.com www.empr.com
1 tags.crwdcntrl.net www.empr.com
1 link.email.empr.com 1 redirects
232 51
Subject Issuer Validity Valid
*.empr.com
RapidSSL RSA CA 2018
2019-01-16 -
2021-01-15
2 years crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA
2019-02-18 -
2020-02-27
a year crt.sh
*.googleapis.com
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA
2019-03-15 -
2021-04-07
2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2018-12-03 -
2019-10-25
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
content.maropost.com
Amazon
2018-10-25 -
2019-11-25
a year crt.sh
*.google.com
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-20 -
2020-02-26
6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-07-26 -
2020-02-01
6 months crt.sh
accounts.haymarketmedia.com
Amazon
2018-10-26 -
2019-11-26
a year crt.sh
*.cloudfront.net
DigiCert Global CA G2
2019-07-17 -
2020-07-05
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-08-24 -
2019-10-19
2 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018
2018-01-22 -
2020-07-29
3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
medtargetsystem.com
Amazon
2018-11-23 -
2019-12-23
a year crt.sh
*.ml314.com
Amazon
2019-03-16 -
2020-04-16
a year crt.sh
certify.alexametrics.com
Amazon
2019-07-26 -
2020-08-26
a year crt.sh
www.google.de
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2019-07-11 -
2019-10-09
3 months crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1
2018-01-26 -
2020-01-06
2 years crt.sh
subapi.haymarketmedia.com
Amazon
2019-06-28 -
2020-07-28
a year crt.sh
*.spotible.com
Go Daddy Secure Certificate Authority - G2
2016-10-16 -
2019-11-06
3 years crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
www.google.com
GTS CA 1O1
2019-08-23 -
2019-11-21
3 months crt.sh
*.b2c.com
Amazon
2019-03-24 -
2020-04-24
a year crt.sh
adtrackapi.haymarketmedia.com
Amazon
2019-03-27 -
2020-04-27
a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh

This page contains 11 frames:

Primary Page: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Frame ID: 93D46EAF527A20FE316DCB022BFABAD7
Requests: 204 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F&_sid=d6fc1a03-6508-42be-86c5-d9c0199b0ed7&_vid=8e584310-f79e-4efc-93f7-bb3e06abfb50&_ak=35-212-8F62AC13&_flash=false&_th=1568442237|1568442237|1
Frame ID: 8B5DD5D5F8B19973CD96995AE36820C6
Requests: 1 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/2212176f3b05219f5a6d9fdd8a356e86?segments=true&mergestate=true&ts=1568442237553
Frame ID: 630056E8CE02AAA96052148E607727B2
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 47D28F1282458F0226DD8248CCA53B92
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 24F9235B7A11ED3A5DAD77571E6FE61D
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 2546C934C2DC6FA21E603DEEF081C89E
Requests: 2 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvpOGhnaN9_LpI505OMj1wIoba3YW3Pi7kjP8mki1VcyqIGoseqe71aVBZ2ZgW8BtoIth9-C0DSGFEt8j1zfm1IEe2rVv1ggdoeTymbwfNGWNRRo4GjLnw8h9o-YX7s5AQ7W67FgpOjlDYQn2FC_bRE6hOR_KJ1gGPzvhTWbfttGxE9j-XNO9QnqAOei9oILrMUpxuWBd7Hb2fUaTGlg5LxEK02p8BFEdzWsoNl3QQHhmWwI7En_1uODnltnF-rZVzfl5e4snvFdcTSswJEEZSdDg&sig=Cg0ArKJSzEc9MUqoQah7EAE&adurl=
Frame ID: 83376516C6C8154CC7FDC7F8EE41878A
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvHO2U8xb4UWDLTSp427wkMb4ZlBQlb2x5Zv_DNgk6iZo6qg6sskFF97FlD5glbjIwJbEGOlFL5gwbIx-o6JH5AzhLiW0oYWze2qo8nXMlHeAr26cR27jsdPGDClcNTy2QcmjQuqDjFySAkprSzChTxvGIF2pVzmVk9C9aHT1Pz7IiKtnhmZ7KzU6cStg36t311a03X017aVudTJyH-TMV3YMrVSDWawUL9GP1En1lUCtzsqFhMic7ZmZeKZVubHnPA4R4RAZGR&sig=Cg0ArKJSzDAX_DZFAcpCEAE&adurl=
Frame ID: 3CC1ABCF738F5DC784CD5C74680034E0
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvdpQkExDme5w7_GC2NJ6jKoX4mZJgLWKo72YRslOeT6XNVuKNDsiZbxcQDCb8cwG9XTAGeIpmD1gqBRhx7Y1lFY3KFkj0aI9lhmBulFrbXTdM6Z9skz_8Gu4qxY9oJhqv2IIk4_QsLwdmpAOSVGBkypTC-vTZQjmEctykkxbpg67kVLfQDKT2v5jAwB5SyWIgrQibrBmF0eYOlJfqpAW5jv-Awb6DC1vhUn4FBZG8CR0CT1BHitOMvQtQmSlGlnL7iqfg7wqMitA&sig=Cg0ArKJSzL_EtjBB44iYEAE&adurl=
Frame ID: 84873E2AB5D6D87DDC542C8569970ED6
Requests: 8 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/c=14413/rand=444215595/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20fda-approves-first-in-class-treatment-for-ibs-c/med=%23OpR%2397539%23Article%20Tags%20%3A%20Gastrohepatic%20Disorders%2CIrritable%20Bowel%20Syndrome%2CMiscellaneous%20Gastrohepatic%20Disorders/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933%22%7D/rt=ifr
Frame ID: C71C9F96CB94BF7ED8333FB07677EDAC
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&upid=7fhq4wn&upv=1.1.0
Frame ID: B683FFCE5C6A17CAE8A2CEA13C1C606D
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://link.email.empr.com/a/1323/click/68057/5059933/951718768f6a199871913945f75629ecee39d166/bc630065... HTTP 302
    https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsle... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

232
Requests

100 %
HTTPS

40 %
IPv6

33
Domains

51
Subdomains

46
IPs

7
Countries

6079 kB
Transfer

8460 kB
Size

39
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.empr.com/a/1323/click/68057/5059933/951718768f6a199871913945f75629ecee39d166/bc6300650acbcf3b8ee719d2efc8b327882e2709&amp HTTP 302
    https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&c9=
Request Chain 57
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=3ba42351-d6b8-11e9-a44d-22a2169a1b72&aid=136&sid=hmm&val=12 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 65
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=2004929519&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&ul=en-us&de=UTF-8&dt=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=1323850533&gjid=810318166&cid=58522034.1568442237&tid=UA-1290429-2&_gid=50566382.1568442237&_r=1&gtm=2wg9415XFK9V6&cd1=123844%3A0&cd2=gastrohepatic%20disorders%2Cirritable%20bowel%20syndrome%2Cmiscellaneous%20gastrohepatic%20disorders&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=fda%20approves%20first-in-class%20treatment%20for%20ibs-c&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Diana%20Ernst%2C%20RPh&cd35=MPR%20Drug%20News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-09-13&cd64=367&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=news&z=649062454 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_gid=50566382.1568442237&gjid=810318166&_v=j79&z=649062454 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454&slf_rd=1&random=2083126034
Request Chain 71
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151497268606219&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151497268606219%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=Iadu1Q9999OfNlh5&person_id=5978151497268606219&eid=50056
Request Chain 72
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151497268606219 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5NzI2ODYwNjIxORAAGg0I_Y7y6wUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=dbe99c7028add917016b4d17ae365aa7e15da97c304856b440308549644d407df4cb09cee1a4f8eb&person_id=5978151497268606219&eid=50082
Request Chain 73
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151497268606219%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151497268606219%26eid=50220&mm_bnc&mm_bct&UUID=c23c5d7c-8344-4c00-9052-f3ec661cfe3f HTTP 302
  • https://ml314.com/csync.ashx?fp=c23c5d7c-8344-4c00-9052-f3ec661cfe3f&person_id=5978151497268606219&eid=50220
Request Chain 74
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151497268606219 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151497268606219 HTTP 302
  • https://ml314.com/csync.ashx?fp=a3d94424705bcb1ee6cc1edac1019145&eid=50146&person_id=5978151497268606219
Request Chain 75
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2hi8CutFyC1QvlYZoR8nPRM3z6BjV9fVYRuRWsYsRIj0&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2hi8CutFyC1QvlYZoR8nPRM3z6BjV9fVYRuRWsYsRIj0&person_id=5978151497268606219&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 222
  • https://api-54-149-252-201.b2c.com/api/x?FZj5pTlzOvZhNeOl$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 HTTP 302
  • https://api-54-149-252-201.b2c.com:444/api/4?FZj5pTlzOvZhNeOl
Request Chain 224
  • https://api-54-213-250-89.b2c.com/api/x?TNbUIlIUWQRTOUJ5$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 HTTP 302
  • https://api-54-213-250-89.b2c.com:444/api/4?TNbUIlIUWQRTOUJ5
Request Chain 225
  • https://api-54-149-252-201.b2c.com/api/x?d0sNdPVHaHy5lyNs$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249bXByLWRhaWx5ZG9zZS1kbWQtMjAxOTA5MTQmY3BuPWltX2FsbCxwY3BfYWxsLFBWQzIwMTkxMjcwMzUscGNwX21kLEVtYWdsaXR5TU1KdWx5MzBETUQsRW1hZ2xpdHlMTV9BdWcyOERIJmhtU3ViSWQ9JmhtRW1haWw9SFU5OEMtSFV5ampJZTQ1T3BTVl8yTEh5UUstVWFHUVQwJk5JRD0xNTE4MDc0NDkxJmNfaWQ9JmVtYWlsX2hhc2g9NDRkZWEzY2Q0ODM5Yjc5OWYyOTExYjVkNzkyMGQ3N2QmZGw9MCZtcHdlYj0xMzIzLTY4MDU3LTUwNTk5MzMiLCJyZWZlcnJlciQwJCIsImFuY2VzdG9yT3JpZ2lucyQwJGh0dHBzOi8vd3d3LmVtcHIuY29tIiwidmlkZW8kMCQxNjAweDEyMDB4MjQiLCJmcmFtZSQwJDEiLCJoaWRkZW4kMCQwIiwidmlzaWJpbGl0eVN0YXRlJDAkdmlzaWJsZSIsImhhc0ZvY3VzJDAkMCIsIndpbmRvdyQwJDMwMHgyNTAiLCJpbm5lciQwJDMwMHgyNTAiLCJvdXRlciQwJDE2MDB4MTIwMCIsImxvY2FsU3RvcmFnZSQwJEVycm9yOiBUeXBlRXJyb3I6IENhbm5vdCByZWFkIHByb3BlcnR5ICdzZXRJdGVtJyBvZiBudWxsIiwic2Vzc2lvblN0b3JhZ2UkMCQxIiwiYXBwQ29kZU5hbWUkMCRNb3ppbGxhIiwiYXBwTmFtZSQwJE5ldHNjYXBlIiwiYXBwVmVyc2lvbiQwJDUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2IiwiY29va2llRW5hYmxlZCQwJHRydWUiLCJkb05vdFRyYWNrJDAkIiwiaGFyZHdhcmVDb25jdXJyZW5jeSQwJDE2IiwibGFuZ3VhZ2UkMCRlbi1VUyIsInBsYXRmb3JtJDAkTGludXggeDg2XzY0IiwicHJvZHVjdCQwJEdlY2tvIiwicHJvZHVjdFN1YiQwJDIwMDMwMTA3Iiwic2VuZEJlYWNvbiQwJDEiLCJ1c2VyQWdlbnQkMCRNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2IiwidmVuZG9yJDAkR29vZ2xlIEluYy4iLCJ2ZW5kb3JTdWIkMCQiLCJmb250cmVuZGVyJDEkMSIsIndlYmdsJDEkbi9hIiwid2ViZ2wyJDEkMCIsInRpbWUkMiQxNTY4NDQyMjM5NjgyIiwidGltZXpvbmUkMiQtMTIwIiwicGx1Z2lucyQyJE5vbmUiLCJtZW0tdG90YWxKU0hlYXBTaXplJDIkNDguNDYzMzQ2IiwibWVtLXVzZWRKU0hlYXBTaXplJDIkMzQuNTAxMDE4IiwibWVtLWpzSGVhcFNpemVMaW1pdCQyJDIxOTcuODE1Mjk2IiwibmF2aWdhdGlvbi1yZWRpcmVjdENvdW50JDIkMCIsIm5hdmlnYXRpb24tdHlwZSQyJG5hdmlnYXRlIiwiZ2xvYmFscy10aW1lJDQkMC40MTUiLCJnbG9iYWxzJDUkYTM3NTI1YTMiLCJkb2N1bWVudC10aW1lJDckMC41NTUiLCJkb2N1bWVudCQ3JDljOTc5ODUyIiwiY29ubmVjdGlvbiQ3JCIsImRvd25saW5rTWF4JDckIiwiZ2V0VXNlck1lZGlhJDckMiIsImNsb2NrJDExJDQ5NDYiLCJiYXR0ZXJ5JDEzJDEgMSAwIEluZmluaXR5IiwiYXVkaW9jb250ZXh0JDE0JGFmZTRmOWM0IiwiaW50ZXJzZWN0aW9uLXNpemUkMTYkMTU4NXgxMjAwIiwiaW50ZXJzZWN0aW9uLWVudGVyJDE2JDAuNXgwIDMwMHgwIiwiaW50ZXJzZWN0aW9uJDE2JDEwMCIsInNvcnQkNzkkMTQuMzkiLCJmcmFtZXJhdGUkMTM3JDUwIiwiYWRibG9jayQxODAkMA HTTP 302
  • https://api-54-149-252-201.b2c.com:444/api/4?d0sNdPVHaHy5lyNs
Request Chain 236
  • https://api-54-213-66-127.b2c.com/api/x?rMOqFXO7f2NITgHD$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249bXByLWRhaWx5ZG9zZS1kbWQtMjAxOTA5MTQmY3BuPWltX2FsbCxwY3BfYWxsLFBWQzIwMTkxMjcwMzUscGNwX21kLEVtYWdsaXR5TU1KdWx5MzBETUQsRW1hZ2xpdHlMTV9BdWcyOERIJmhtU3ViSWQ9JmhtRW1haWw9SFU5OEMtSFV5ampJZTQ1T3BTVl8yTEh5UUstVWFHUVQwJk5JRD0xNTE4MDc0NDkxJmNfaWQ9JmVtYWlsX2hhc2g9NDRkZWEzY2Q0ODM5Yjc5OWYyOTExYjVkNzkyMGQ3N2QmZGw9MCZtcHdlYj0xMzIzLTY4MDU3LTUwNTk5MzMiLCJyZWZlcnJlciQwJCIsImFuY2VzdG9yT3JpZ2lucyQwJCIsInZpZGVvJDAkMTYwMHgxMjAweDI0IiwiZnJhbWUkMCQwIiwiaGlkZGVuJDAkMCIsInZpc2liaWxpdHlTdGF0ZSQwJHZpc2libGUiLCJoYXNGb2N1cyQwJDEiLCJ3aW5kb3ckMCQxNTg1eDEyMDAiLCJpbm5lciQwJDE2MDB4MTIwMCIsIm91dGVyJDAkMTYwMHgxMjAwIiwibG9jYWxTdG9yYWdlJDEkRXJyb3I6IFR5cGVFcnJvcjogQ2Fubm90IHJlYWQgcHJvcGVydHkgJ3NldEl0ZW0nIG9mIG51bGwiLCJzZXNzaW9uU3RvcmFnZSQxJDEiLCJhcHBDb2RlTmFtZSQxJE1vemlsbGEiLCJhcHBOYW1lJDEkTmV0c2NhcGUiLCJhcHBWZXJzaW9uJDEkNS4wIChNYWNpbnRvc2g7IEludGVsIE1hYyBPUyBYIDEwXzE0XzUpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS83NC4wLjM3MjkuMTY5IFNhZmFyaS81MzcuMzYiLCJjb29raWVFbmFibGVkJDEkdHJ1ZSIsImRvTm90VHJhY2skMSQiLCJoYXJkd2FyZUNvbmN1cnJlbmN5JDEkMTYiLCJsYW5ndWFnZSQxJGVuLVVTIiwicGxhdGZvcm0kMSRMaW51eCB4ODZfNjQiLCJwcm9kdWN0JDEkR2Vja28iLCJwcm9kdWN0U3ViJDEkMjAwMzAxMDciLCJzZW5kQmVhY29uJDEkMSIsInVzZXJBZ2VudCQxJE1vemlsbGEvNS4wIChNYWNpbnRvc2g7IEludGVsIE1hYyBPUyBYIDEwXzE0XzUpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS83NC4wLjM3MjkuMTY5IFNhZmFyaS81MzcuMzYiLCJ2ZW5kb3IkMSRHb29nbGUgSW5jLiIsInZlbmRvclN1YiQxJCIsImZvbnRyZW5kZXIkMiQxIiwid2ViZ2wkMyRuL2EiLCJ3ZWJnbDIkMyQwIiwidGltZSQzJDE1Njg0NDIyNDAyNzQiLCJ0aW1lem9uZSQzJC0xMjAiLCJwbHVnaW5zJDMkTm9uZSIsIm1lbS10b3RhbEpTSGVhcFNpemUkNCQ1MC44NTQyMiIsIm1lbS11c2VkSlNIZWFwU2l6ZSQ0JDI5LjA0NTAwNCIsIm1lbS1qc0hlYXBTaXplTGltaXQkNCQyMTk3LjgxNTI5NiIsInRpbWUtZmV0Y2hTdGFydCQ0JDE0MCIsInRpbWUtZG9tYWluTG9va3VwU3RhcnQkNCQxNDAiLCJ0aW1lLWRvbWFpbkxvb2t1cEVuZCQ0JDE0MCIsInRpbWUtY29ubmVjdFN0YXJ0JDQkMTQwIiwidGltZS1jb25uZWN0RW5kJDQkMTQwIiwidGltZS1yZXF1ZXN0U3RhcnQkNCQxNDAiLCJ0aW1lLXJlc3BvbnNlU3RhcnQkNCQyMzgiLCJ0aW1lLXJlc3BvbnNlRW5kJDQkMjQyIiwidGltZS1kb21Mb2FkaW5nJDQkMjQ5IiwidGltZS1kb21JbnRlcmFjdGl2ZSQ0JDg3NiIsInRpbWUtZG9tQ29udGVudExvYWRlZEV2ZW50U3RhcnQkNCQxNTI1IiwidGltZS1kb21Db250ZW50TG9hZGVkRXZlbnRFbmQkNCQxNTU5IiwidGltZS1kb21Db21wbGV0ZSQ0JDM2MDAiLCJ0aW1lLWxvYWRFdmVudFN0YXJ0JDQkMzYwMCIsInRpbWUtbG9hZEV2ZW50RW5kJDQkMzYyNCIsIm5hdmlnYXRpb24tcmVkaXJlY3RDb3VudCQ0JDAiLCJuYXZpZ2F0aW9uLXR5cGUkNCRuYXZpZ2F0ZSIsImdsb2JhbHMtdGltZSQ5JDAuNzQiLCJnbG9iYWxzJDkkYTM3NTI1YTMiLCJkb2N1bWVudC10aW1lJDE0JDAuODMiLCJkb2N1bWVudCQxNCQ5Yzk3OTg1MiIsImNvbm5lY3Rpb24kMTQkIiwiZG93bmxpbmtNYXgkMTQkIiwiZ2V0VXNlck1lZGlhJDE0JDIiLCJjbG9jayQxOSQzNzExIiwiYmF0dGVyeSQyMiQxIDEgMCBJbmZpbml0eSIsImludGVyc2VjdGlvbi1zaXplJDIyJDE1ODV4MTIwMCIsImludGVyc2VjdGlvbiQyMiQyOSIsImF1ZGlvY29udGV4dCQyMyRhZmU0ZjljNCIsInNvcnQkNTIkMTAuOTkiLCJmcmFtZXJhdGUkMTI2JDgwIiwiYWRibG9jayQxOTkkMA HTTP 302
  • https://api-54-213-66-127.b2c.com:444/api/4?rMOqFXO7f2NITgHD

232 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/
Redirect Chain
  • http://link.email.empr.com/a/1323/click/68057/5059933/951718768f6a199871913945f75629ecee39d166/bc6300650acbcf3b8ee719d2efc8b327882e2709&amp
  • https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_m...
101 KB
22 KB
Document
General
Full URL
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
20325a6c8dda84b75e49393c3a432d8ee089f930742af485f356b0956be16041

Request headers

:method
GET
:authority
www.empr.com
:scheme
https
:path
/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Sat, 14 Sep 2019 06:23:56 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.empr.com/xmlrpc.php
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=123844>; rel=shortlink
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
HIT: 1
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
77e343a3-c287-4923-91fa-bcbe68f5c94f
Location
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
X-Runtime
0.026810
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Sat, 14 Sep 2019 06:23:56 GMT
Set-Cookie
_session_id=52fabe7af5a514c3f3d73b50fe1dd723; path=/; expires=Sat, 14 Sep 2019 18:23:56 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/
29 KB
5 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
48 KB
7 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
240 KB
32 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-3bfb4"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/
8 KB
814 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sat, 14 Sep 2019 06:23:56 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sat, 14 Sep 2019 06:23:56 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:56 GMT
lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
39 KB
3 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-9de9"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/
825 B
455 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sat, 14 Sep 2019 06:23:56 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sat, 14 Sep 2019 06:23:56 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:56 GMT
autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/
766 B
581 B
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-2fe"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
jquery-migrate.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
10 KB
4 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cookie.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cc.js
tags.crwdcntrl.net/c/14413/
39 KB
11 KB
Script
General
Full URL
https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40E9) /
Resource Hash
207775987f53f3b91160546806345706ec562f294cb076637004e36d81ef221b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 01:01:17 GMT
server
ECS (fcn/40E9)
etag
"5d7998dd-9b68+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11493
expires
Sun, 15 Sep 2019 06:23:56 GMT
digest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
16 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
UtilityMove-custom.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
polyfill.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
gpt.js
www.googletagservices.com/tag/js/
41 KB
13 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
76ae2a71f0853ebc2535d93b1e9c454a9f28617c168afed14329394a86ed766f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"278 / 559 of 1000 / last-modified: 1568323759"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
13175
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:56 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/
19 KB
19 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.138.157 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
CDC0952AD0D523BB
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
LBqS9jBFX9Cby0ytrLiUnWYTyD48MsoNsZsq+G3t02DiltSztNwby/4TwJIR6hoHXj/S2DMp3lM=
head.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
44 KB
13 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1568281912
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
454b56eb2367b33e6f99edc171815d9a69267263af086b343b8b8aad13ed4c63

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-ae1e"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/
16 KB
16 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
etag
"452a9f099947d43a38734d72a92e9193"
last-modified
Wed, 20 Mar 2019 21:55:07 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
16492
expires
Fri, 20 Sep 2019 11:33:34 GMT
gtm.js
www.googletagmanager.com/
138 KB
34 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
0827806e096ae5c98979dc41695cec6d47c1a0923c9ba5215020ba21f093fb71
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
br
last-modified
Sat, 14 Sep 2019 06:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
34845
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:56 GMT
Diana-Ernst-newprofile-pic-96x96.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/
3 KB
3 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/Diana-Ernst-newprofile-pic-96x96.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
50abb28802f1e77b63ff2dee64a92ab7f6f2e1df12b7d66d513fa21eacca57b4
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
etag
"4c180f21b1b74a261040e1e9217c13a3"
last-modified
Sat, 17 Aug 2019 07:11:47 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
2589
expires
Wed, 02 Oct 2019 05:13:23 GMT
ibs-stomach-NS.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/04/
10 KB
11 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/04/ibs-stomach-NS.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3aac22d007d09a5956a4b880d95d7824c511f652643f719a2eb25552c371e00e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
etag
"f57c747c41f5c76a0fbecd9d122bc6de"
last-modified
Sat, 13 Apr 2019 07:11:57 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
10542
expires
Sun, 13 Oct 2019 17:08:27 GMT
300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/
13 KB
14 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
etag
"fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified
Wed, 20 Mar 2019 09:05:43 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/gif
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13667
expires
Fri, 20 Sep 2019 12:01:48 GMT
spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/
694 B
631 B
Image
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js
content.maropost.com/uploads/1323/websites/5/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:ae00:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:18:12 GMT
via
1.1 8cdf0467c0468ddfe8e9873c6bb8304c.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:48:02 GMT
server
AmazonS3
age
345
etag
"ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
2622
x-amz-cf-id
FJYS8cd_vXnujDSSYl5QdkUjMNkt1mrewSEoofWFQm8gM-mdTt8HXQ==
blocks.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
local-storage-lib.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
1 KB
917 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
npi-manager.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
3 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-b3b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
799 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.138.157 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
805EE10C7B47F3BF
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
csLBKnYjTffo31CifRF6x383B2E_amuJ
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
mbI1HF2yDLiapMvxgldk0USYypcpVmWx/ubsfhirzz0JMw+mahMkBPZbIcXBHlQU2/nZ2iljEt8=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
357 KB
357 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.138.157 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
E3659AD431BD7D7A
ETag
"dfdfd93abc9eec4ff346a12a61df7c41"
Content-Type
application/javascript
x-amz-version-id
6ACuZZ4Fakkhaw3IL9mD952B0XZGZK4Q
Accept-Ranges
bytes
Content-Length
365119
x-amz-id-2
MiOQMxXkq6Mw7RSukDCgtVutzD2fin9m4hXDag4IAav4QnCkKGaJLInbcqGXiPbO7gCbadf8M/Y=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.138.157 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
CF5AB8085CC6C0D8
ETag
"8f47379688c3f5980d42b891fcaea0eb"
Content-Type
application/javascript
x-amz-version-id
1g9qbXhjK6v_p1EyiVTzg_c7stFBXUFD
Accept-Ranges
bytes
Content-Length
1225121
x-amz-id-2
9wJ1u2Rw3M8LmcuCT6LfTY5cMDlX9wWzn/Ku6daZb7Q4g4IY+jX1RTRrlFUKMKpENw6SCq1sGcs=
autosuggest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/
17 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6258dbe6dbce7a7de872ad56d9ceea8354f5d37626e66201ec29b2717a95e949

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-4361"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
frontend.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
147 KB
39 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
be6beaacd90961241ca111e54c0953bc476a844a264e5afade4792a75c78c540

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-24c66"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
iab.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
wp-embed.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/
1 KB
1003 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
integrator.js
adservice.google.de/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
pubads_impl_2019090901.js
securepubads.g.doubleclick.net/gpt/
157 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
sffe /
Resource Hash
d2064583dc074f40b117a6e11043ea853c50bc49954b5ac936a48d9482d36fa7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 09 Sep 2019 13:07:13 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
59061
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:57 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/
87 KB
28 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435678
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0a2b71ee206e66ae16bd0904a7ecb5ae5288bd11ce6d963917e2ebc8ab1212d0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 a01b7aca64c6d4b437b814f64422d6c8.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
1373
cf-polished
origSize=89183
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 13:24:04 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
VIE50-C1
cf-ray
5160466eab9dcba8-VIE
x-amz-cf-id
zfNKs8lzNGAD6Mqu3UzBcCq5ktPX28brugXoeRkrjC_aEvk0YwUELw==
cf-bgj
minify
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
6024
date
Sat, 14 Sep 2019 04:43:33 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
17803
expires
Sat, 14 Sep 2019 06:43:33 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnew...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&c9=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:23:57 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1568442236936&ns_c=UTF-8&c8=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&c9=
Pragma
no-cache
Date
Sat, 14 Sep 2019 06:23:57 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/
33 KB
10 KB
Other
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:36:09 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
1615668
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14044
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:36:09 GMT
chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/
190 B
399 B
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:27:01 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:27:03 GMT
server
sffe
age
1616216
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11388
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:27:01 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 02 Sep 2019 15:53:22 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:19:23 GMT
server
sffe
age
1002635
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11272
x-xss-protection
0
expires
Tue, 01 Sep 2020 15:53:22 GMT
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 21 Aug 2019 21:19:20 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
2019877
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14176
x-xss-protection
0
expires
Thu, 20 Aug 2020 21:19:20 GMT
S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
fonts.gstatic.com/s/lato/v16/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fe4bbdad1d6dff75cde79f8afc07f29502bd4708cb0ce5f552083c3d81ba8382
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 02 Sep 2019 10:53:04 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:51 GMT
server
sffe
age
1020653
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14864
x-xss-protection
0
expires
Tue, 01 Sep 2020 10:53:04 GMT
js
www.google-analytics.com/gtm/
55 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=58522034.1568442237
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
68f9f54f67e00afa33ee3a0cb427cbf8eb6fda2f93747de18b23d0b1d3c38409
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
br
last-modified
Sat, 14 Sep 2019 06:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
21106
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:57 GMT
96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=5059933&campaign_id=68057&title=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
2d957b5407e3d535b44fdaa6009e16640c0b72324db7022bc85161d9d06a5079
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
b7554ae7-71a1-4ef2-a5d2-366b49fa2240
X-Runtime
0.029052
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"24c9533bc5e35d364774db05040f586c"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/
45 KB
11 KB
Script
General
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
5160466f5c0ecb98-VIE
date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
5229
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sat, 14 Sep 2019 08:23:57 GMT
most-widget
www.empr.com/wp-json/haymarket/v1/
4 KB
2 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
043ca1ffc732a6a441e214ad2541a9c14f631d97e13f6b96f797d5d25efe8e9e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 20
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
123844
www.empr.com/wp-json/haymarket/v1/infinite-scroll/
5 KB
2 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/123844
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c05f6c89c66277fdd1f4dc8663c687de14633cd5d4e35b89974c33927ed77c3b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 1
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.empr.com/wp-json/haymarket/v1/
58 B
491 B
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d7b32b5c219a591a8d4c1b3fbf363951965e2d9917e66fda462d77cd4149e5cb
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 7
status
200
x-wpengine-segment
NONHT
vary
Accept-Encoding,Cookie
content-length
58
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
server
nginx
allow
GET
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
accept-ranges
bytes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/
45 B
440 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.213.112.55 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-213-112-55.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.empr.com
cache-control
private
access-control-allow-credentials
true
content-length
45
atrk.js
d31qbv1cthcecs.cloudfront.net/
4 KB
2 KB
Script
General
Full URL
https://d31qbv1cthcecs.cloudfront.net/atrk.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.71 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-71.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 14 Jun 2019 00:48:51 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Sat, 16 Mar 2019 16:01:33 GMT
Server
AmazonS3
Age
7968907
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
text/javascript
Via
1.1 8e04f5d6c745b231c10fce7c2aa9c70f.cloudfront.net (CloudFront)
Cache-Control
max-age=26920000
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA6-C1
X-Amz-Cf-Id
1yEnZO0zT8sgPXl4RAAks6pJINnF5L2kI08d8IPzm6luYeLGbNZbiw==
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
fbevents.js
connect.facebook.net/en_US/
121 KB
31 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
31604
x-xss-protection
0
pragma
public
x-fb-debug
bTJWcFm+tt0J4OdXespWxUhxE4zzZgLgAfuIETV3V8ZFgXYBorOL4eiOaH9q8LsZ5JJYRvHHrtwsBZ6UPBOSKA==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sat, 14 Sep 2019 06:23:57 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://mt.sitomobile.com/sync/tacb?exid=3ba42351-d6b8-11e9-a44d-22a2169a1b72&aid=136&sid=hmm&val=12
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B
Script
General
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.65.223 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-65-223.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/
6 KB
2 KB
Script
General
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.32.220.201 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-32-220-201.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 13 Sep 2019 19:03:30 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
40828
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 40b36a86ab4ea993a78087b1ceb80e25.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA56
X-Amz-Cf-Id
xRUAjEk-bW8QFCvrqfDFwTkK1rPE3l0-sS9UuxC4iImjf-wYAltCBA==
beacon.js
www.medtargetsystem.com/javascript/
177 KB
52 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.3.171.116 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-3-171-116.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
299979d7049132d5ae572e40845ca758051cafee7c527247d75d96a49eab3a7b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Encoding
gzip
Last-Modified
Fri, 06 Sep 2019 19:12:31 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c45a-591e73843e5c0-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52903
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
920 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 05:25:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3481
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
856
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:25:56 GMT
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?1482019
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Encoding
gzip
Last-Modified
Sat, 14 Sep 2019 05:34:26 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=83428
Connection
keep-alive
Content-Length
11933
Expires
Sun, 15 Sep 2019 05:34:26 GMT
io.min.js
c.lytics.io/static/v2/
13 KB
6 KB
Script
General
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
b2435070f04e40c2666a729a016c60355b2025c969c3b7857489b7c8b2755bc2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
5160466f9ca0cb98-VIE
date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 26 Jun 2019 19:48:45 GMT
server
cloudflare
age
285
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sat, 14 Sep 2019 08:23:57 GMT
atrk.gif
certify.alexametrics.com/
43 B
551 B
Image
General
Full URL
https://certify.alexametrics.com/atrk.gif?frame_height=1200&frame_width=1600&iframe=0&title=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&time=1568442237366&time_zone_offset=-120&screen_params=1600x1200x24&java_enabled=0&cookie_enabled=1&ref_url=&host_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&random_number=1636310684&sess_cookie=1101a0c016d2e7141b5fc8b3562&sess_cookie_flag=1&user_cookie=1101a0c016d2e7141b5fc8b3562&user_cookie_flag=1&dynamic=true&domain=empr.com&account=gujPp1NErb205V&jsv=20130128&user_lang=en-US
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.35.253.107 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-35-253-107.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 02:22:33 GMT
Via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront)
Last-Modified
Mon, 17 Jan 2011 20:41:40 GMT
Server
AmazonS3
Age
23998
ETag
"221d8352905f2c38b3cb2bd191d630b0"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
Accept-Ranges
bytes
X-Amz-Cf-Pop
FRA6-C1
x-amz-meta-alexa-last-modified
20110117123941
Content-Length
43
X-Amz-Cf-Id
vPC8FPIL7NE06HopLLoedP-HAap2pWH7vHjMybwZPz1PAWGwdUrrwA==
1073716492693685
connect.facebook.net/signals/config/
307 KB
78 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
QB2f7N29hszZt8ET9Tyit+nV0/ZcIHr8LVD9NWqDYgOpkOa8a63RfgdvguZZTzzg29EglUbA6mwFOgIjiZbMDQ==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sat, 14 Sep 2019 06:23:57 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=2004929519&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dne...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_gid=50566382.1568442237&gjid=810318166&_v=j79&z=649062454
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454&slf_rd=1&random=2083126034
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454&slf_rd=1&random=2083126034
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:57 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:57 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=58522034.1568442237&jid=1323850533&_v=j79&z=649062454&slf_rd=1&random=2083126034
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
utsync.ashx
ml314.com/
793 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&pv=1568442237384_n7xdyue88&bl=en-us&cb=6167252&return=&ht=&d=&dc=&si=1568442237384_n7xdyue88&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?1482019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
85f46964e5bc9941193a128b224ac750d5588490c6a976ee3d39fbead0af7338

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
486
Expires
0
ud.ashx
in.ml314.com/
20 B
698 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=1482019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?1482019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.109.111 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-233-109-111.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:56 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Sun, 15 Sep 2019 06:23:57 GMT
inferredEvents.js
connect.facebook.net/signals/plugins/
35 KB
10 KB
Script
General
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
10218
x-xss-protection
0
pragma
public
x-fb-debug
/1yXM56Jr/KRumJh1/JTN6/esKboOXAJKp1MROt1kMS0X/nR2Q2NS51LNzTCg3fgNVmQzIzeHhj+G+8PLJRetQ==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sat, 14 Sep 2019 06:23:57 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
4
c.lytics.io/cid/
77 B
192 B
Script
General
Full URL
https://c.lytics.io/cid/4?callback=jQuery112406286059269455311_1568442236834&_=1568442236835
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
56f3d4bb5211c212703a566e89adeca84a8ef1760f62ac519e5535679b5260d8

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
5160466fdd57cb98-VIE
pragma
no-cache
date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
/
www.facebook.com/tr/
44 B
245 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&rl=&if=false&ts=1568442237409&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1568442237408.1352123813&it=1568442237371&coo=false&rqm=GET
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:57 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Sat, 14 Sep 2019 06:23:57 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151497268606219&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151497268606219%26eid=50056
  • https://ml314.com/csync.ashx?fp=Iadu1Q9999OfNlh5&person_id=5978151497268606219&eid=50056
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=Iadu1Q9999OfNlh5&person_id=5978151497268606219&eid=50056
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 15 Sep 2019 02:23:57 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=Iadu1Q9999OfNlh5&person_id=5978151497268606219&eid=50056
Date
Sat, 14 Sep 2019 06:23:57 GMT
Connection
keep-alive
Content-Length
0
BK-Server
95d9
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151497268606219
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5NzI2ODYwNjIxORAAGg0I_Y7y6wUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=dbe99c7028add917016b4d17ae365aa7e15da97c304856b440308549644d407df4cb09cee1a4f8eb&person_id=5978151497268606219&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=dbe99c7028add917016b4d17ae365aa7e15da97c304856b440308549644d407df4cb09cee1a4f8eb&person_id=5978151497268606219&eid=50082
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 15 Sep 2019 02:23:57 GMT

Redirect headers

date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=dbe99c7028add917016b4d17ae365aa7e15da97c304856b440308549644d407df4cb09cee1a4f8eb&person_id=5978151497268606219&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151497268606219%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151497268606219%26eid=50220&mm_bnc&mm_bct&UUID=c23c5d7c-8344-4c00-9052-f3ec661cfe3f
  • https://ml314.com/csync.ashx?fp=c23c5d7c-8344-4c00-9052-f3ec661cfe3f&person_id=5978151497268606219&eid=50220
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=c23c5d7c-8344-4c00-9052-f3ec661cfe3f&person_id=5978151497268606219&eid=50220
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 15 Sep 2019 02:23:57 GMT

Redirect headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
MT3 1684 2519bb0 master zrh-pixel-x23
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=c23c5d7c-8344-4c00-9052-f3ec661cfe3f&person_id=5978151497268606219&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Sat, 14 Sep 2019 06:23:56 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151497268606219
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151497268606219
  • https://ml314.com/csync.ashx?fp=a3d94424705bcb1ee6cc1edac1019145&eid=50146&person_id=5978151497268606219
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=a3d94424705bcb1ee6cc1edac1019145&eid=50146&person_id=5978151497268606219
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 15 Sep 2019 02:23:57 GMT

Redirect headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:23:57 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=a3d94424705bcb1ee6cc1edac1019145&eid=50146&person_id=5978151497268606219
Cache-Control
no-cache
X-Server
10.45.22.159
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2hi8CutFyC1QvlYZoR8nPRM3z6BjV9fVYRuRWsYsRIj0&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2hi8CutFyC1QvlYZoR8nPRM3z6BjV9fVYRuRWsYsRIj0&person_id=5978151497268606219&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B
Image
General
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.120.224.89 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-120-224-89.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Sat, 14 Sep 2019 06:23:56 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Sun, 15 Sep 2019 02:23:57 GMT
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame 8B5D
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F&_sid=d6fc1a03-6508-42be-86c5-d9c0199b0ed7&_vid=8e584310-f79e-4efc-93f7-bb3e06abfb50&_ak=35-212-8F62AC13&_flash=false&_th=1568442237|1568442237|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.3.171.116 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-3-171-116.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Sat, 14 Sep 2019 06:23:57 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=qiglsnsmu56a4ot0rciprhhr20; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6989
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=8e584310-f79e-4efc-93f7-bb3e06abfb50&sid=d6fc1a03-6508-42be-86c5-d9c0199b0ed7&vh=1&vt=1568442237&pt=1568442237&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&r=&t=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&p=1012.17&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.3.171.116 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-3-171-116.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:57 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
2212176f3b05219f5a6d9fdd8a356e86
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame 6300
0
0
Document
General
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/2212176f3b05219f5a6d9fdd8a356e86?segments=true&mergestate=true&ts=1568442237553
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io a8490f1ba846e083c65cfb3c56ec54b5dee489d0 /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/2212176f3b05219f5a6d9fdd8a356e86?segments=true&mergestate=true&ts=1568442237553
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
accept-encoding
gzip, deflate, br
cookie
__cfduid=dfad24f630174c2de11faaecb7974ee3a1568442237; seerid=2212176f3b05219f5a6d9fdd8a356e86
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io a8490f1ba846e083c65cfb3c56ec54b5dee489d0
date
Sat, 14 Sep 2019 06:23:57 GMT
content-length
294
via
1.1 google
alt-svc
clear
/
www.facebook.com/tr/ Frame 47D2
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3656
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
accept-encoding
gzip, deflate, br
cookie
fr=0ycGlsnfLayaqVnGq..BdfId9...1.0.BdfId9.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Sat, 14 Sep 2019 06:23:57 GMT
pathfora.min.js
c.lytics.io/static/
98 KB
20 KB
Script
General
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51604672fbc7cb98-VIE
date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
265
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sat, 14 Sep 2019 08:23:57 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
116 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1568442237875&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604672fbcecb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1568442236752&event=gtm.js&gtm.uniqueEventId=4&_ts=1568442237877&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604672fbcfcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1568442237877&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604672fbd0cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1568442237878&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604672fbd1cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=123844%3A0&_ts=1568442237880&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604672fbd2cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=MPR%20Drug%20News&_ts=1568442237880&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046731c0fcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1568442237881&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673dd4acb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1568442237882&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673dd58cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1568442237882&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673dd5acb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1568442237883&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673dd5bcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1568442237884&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673dd5dcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
166 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1568442237884&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604673fd8ecb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1568442237884&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674cf2dcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1568442237885&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674cf30cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Diana%20Ernst%2C%20RPh&_ts=1568442237885&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674df48cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1568442237886&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674df49cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1568442237886&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674df4acb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1568442237887&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604674df50cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
231 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1568442237887&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675b94fcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1568442237888&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675b951cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1568442237888&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675b960cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1568442237889&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675b967cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1568442237889&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675b96acb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1568442237890&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604675f9c6cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1568442237891&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046769b2fcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1568442237891&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046769b33cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1568442237891&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046769b35cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-09-13&_ts=1568442237892&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046769b3dcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1568442237892&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604676ab47cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=367&_ts=1568442237892&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604676dbbacb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1568442237892&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046778d9bcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1568442237893&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046778da1cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1568442237893&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046778da3cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1568442237893&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046778dadcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1568442237893&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046778dbfcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1568442237894&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604677ce93cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Afda%20approves%20first-in-class%20treatment%20for%20ibs-c&_ts=1568442237894&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046786814cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=&_ts=1568442237894&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046786815cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=gastrohepatic%20disorders%2Cirritable%20bowel%20syndrome%2Cmiscellaneous%20gastrohepatic%20disorders&_ts=1568442237894&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046786816cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=news&_ts=1568442237895&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604678681acb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1568442237895&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046787831cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1568442237895&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:58 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604678c8f9cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1568442237896&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046795a3bcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=0&_ts=1568442237896&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046795a3ecb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=&_ts=1568442237897&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046795a40cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
116 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1568442237897&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046795a41cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=&_ts=1568442237897&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
516046795a4dcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1568442237898&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51604679aaefcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1568442237898&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a4c53cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1568442237898&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a4c54cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1568442237899&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a4c55cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=im_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH&_ts=1568442237899&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a4c5dcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1568442237899&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a4c61cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1568442237899&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467a8cdbcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1568442237899&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b2e3bcb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1568442237900&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b2e3ccb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=false&_ts=1568442237900&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b2e55cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1568442237900&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b2e56cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1518074491&_ts=1568442237900&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b2e57cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
103 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1568442237288&event=gtm.js&gtm.uniqueEventId=3&_ts=1568442237900&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&_uid=2212176f3b05219f5a6d9fdd8a356e86&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
5160467b6ec5cb98-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
2212176f3b05219f5a6d9fdd8a356e86
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/
172 KB
27 KB
XHR
General
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/2212176f3b05219f5a6d9fdd8a356e86?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io a8490f1ba846e083c65cfb3c56ec54b5dee489d0 /
Resource Hash
b8facf7b37442ba04dc921f6284e9e7d77f312f1a52ed430ff77f026c4ffe6b5

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
content-encoding
gzip
server
lytics.io a8490f1ba846e083c65cfb3c56ec54b5dee489d0
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.empr.com
alt-svc
clear
via
1.1 google
/
www.facebook.com/tr/ Frame 24F9
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
11406
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
accept-encoding
gzip, deflate, br
cookie
fr=0ycGlsnfLayaqVnGq..BdfId9...1.0.BdfId9.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Sat, 14 Sep 2019 06:23:57 GMT
pathfora.min.css
c.lytics.io/static/
20 KB
3 KB
Stylesheet
General
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
516046732c28cb98-VIE
date
Sat, 14 Sep 2019 06:23:57 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
289
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sat, 14 Sep 2019 08:23:57 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/
78 KB
10 KB
Script
General
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5465 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
196faeba2479b49e3e896bb4f846a5d5842e4f639be08d03f023e41154df22aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
5160467bfff1cb98-VIE
date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
5226
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sat, 14 Sep 2019 08:23:59 GMT
css
fonts.googleapis.com/
1 KB
477 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sat, 14 Sep 2019 06:23:58 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sat, 14 Sep 2019 06:23:58 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:58 GMT
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
collect.gif
www.medtargetsystem.com/analytics/
0
245 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=8e584310-f79e-4efc-93f7-bb3e06abfb50&sid=d6fc1a03-6508-42be-86c5-d9c0199b0ed7&vh=2&vt=1568442237&pt=1568442238&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&r=&t=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&p=1558.80&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.3.171.116 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-3-171-116.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
hivinfectioncd4cellsss468_1159086.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
122 KB
123 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hivinfectioncd4cellsss468_1159086.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
47bc305eb82af2bd196db29a335a223c0ab8cf72534dd5378460bfb59d104116
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 21:51:52 GMT
server
nginx
etag
"8ab57440d1581d97b40de60be8e01c1a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
125365
expires
Mon, 14 Oct 2019 06:23:58 GMT
organicfoodg944864586_1496974.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
47 KB
48 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/organicfoodg944864586_1496974.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
f792a4f69f60e05d36f5061d41c16a4995d1414b32de3dab4eaa665e527ea2a8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:42:48 GMT
server
nginx
etag
"876f8253cfe4bce8065ebc570c8be3aa"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
48371
expires
Mon, 14 Oct 2019 06:23:58 GMT
omronbpwatchbk_1521627.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
16 KB
16 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/omronbpwatchbk_1521627.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6d08799af7bbe3a6ce5a2e880027032b9c466cc3ebad005238c2edb6fbf5607f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 09:02:47 GMT
server
nginx
etag
"09ab43e036092504bf79f50f36ac6778"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
15944
expires
Mon, 14 Oct 2019 06:23:58 GMT
blurredhospitalpatientss39_1185726.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
106 KB
107 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/blurredhospitalpatientss39_1185726.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a10b9d97b6e4574362df2c48bc98a9aa485ac83efe6f32e53a660bbd16d3bc39
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Thu, 21 Mar 2019 00:01:13 GMT
server
nginx
etag
"5db721e4a11a8c72dcc870ae07920831"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
108974
expires
Mon, 14 Oct 2019 06:23:58 GMT
wixelaproductimage_1527060.png
www.empr.com/wp-content/uploads/sites/7/2019/02/
549 KB
550 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/wixelaproductimage_1527060.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
67645b8680623d876dfcc3516b5edba8df2f9af5b297e647da40da7e14ef1206
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 09:12:45 GMT
server
nginx
etag
"b39f3da8a2cfea3931f341389a641cdf"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
562335
expires
Mon, 14 Oct 2019 06:23:58 GMT
pneumoniawordss304309484_1195812.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
192 KB
192 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/pneumoniawordss304309484_1195812.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
30ac3b546e30337b5600d88e243361ea434ff3b8365e220134c5b0569350066a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 19:48:31 GMT
server
nginx
etag
"9af8d62ad5f72220d1fdf854ec594c98"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
196298
expires
Mon, 14 Oct 2019 06:23:58 GMT
dsuviaapplicator_1495784.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
12 KB
12 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/dsuviaapplicator_1495784.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
da7767cff027df59981c24026ba0a5e75adfa7af9f6194e2a407b410f61c74a2
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Thu, 21 Mar 2019 01:41:53 GMT
server
nginx
etag
"8d2c05210fdd2405b7c4e1d078eb0601"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
12020
expires
Mon, 14 Oct 2019 06:23:58 GMT
dealogo_1360708.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
62 KB
63 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/dealogo_1360708.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ecb5a66c3beb8786964427668b1faea4b882a7a511f024004b4e58e3203ce39f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 21:59:58 GMT
server
nginx
etag
"674d6a062f3973def5b46a17eaf8c83c"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
63907
expires
Mon, 14 Oct 2019 06:23:58 GMT
481542otezla30mgsinglens_963850.png
www.empr.com/wp-content/uploads/sites/7/2018/12/
139 KB
139 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/481542otezla30mgsinglens_963850.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
643785cbdf05e8cbc1f03dcb412c95c14bfb8eb067980c5bd7c4d7d8b805b74a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:50:03 GMT
server
nginx
etag
"61a590d2eb564fad1e3ea49dbd8cadce"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
142188
expires
Mon, 14 Oct 2019 06:23:58 GMT
genericro_969021.png
www.empr.com/wp-content/uploads/sites/7/2018/12/
177 KB
178 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/genericro_969021.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8accf582ee904ff97dd0439d424181b266e8e55b781563fcd67ba5c1d29fc784
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:38:12 GMT
server
nginx
etag
"2ed7f587711d0990fd099dfae036d29c"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
181314
expires
Mon, 14 Oct 2019 06:23:58 GMT
FDA-HQ-1.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
44 KB
44 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-HQ-1.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Sun, 28 Apr 2019 07:11:12 GMT
server
nginx
etag
"281477ab9f7eb60e6b7d1f61e45fe582"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45105
expires
Mon, 14 Oct 2019 06:23:58 GMT
manholdingstomachns_945610.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
215 KB
216 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/manholdingstomachns_945610.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
368b14e38bc8a2a3c03d952ba8955b8173e7e0294de5ba30f0cb2a24c4e1c416
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 19:37:35 GMT
server
nginx
etag
"cd55ed3603e13e53e6747b6003a3e2ac"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
220314
expires
Mon, 14 Oct 2019 06:23:58 GMT
chronickidneydiseasess7127_1293178.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
30 KB
31 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/chronickidneydiseasess7127_1293178.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e597865ddb5e03f7c256f1f1da291fe5df162acc87c9419df55c9fc7044675e3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:50:53 GMT
server
nginx
etag
"1b9fc7a1f693b667dde630c86b427591"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
31214
expires
Mon, 14 Oct 2019 06:23:58 GMT
lupinlogons_950795.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
67 KB
67 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/lupinlogons_950795.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
63df35f91cbcdaeaebd41e3612c181201e3b9a219c0cfb4e03390aa41aa3dbc0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:41:12 GMT
server
nginx
etag
"408b27cf5a87831592c552b52e593a85"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
68374
expires
Mon, 14 Oct 2019 06:23:58 GMT
Adhansia-XR.jpg
www.empr.com/wp-content/uploads/sites/7/2019/06/
19 KB
19 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/06/Adhansia-XR.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
206a40b0d9084415064c358a1a381b3a05b27de806b4e62ffefb1b7be2da3bd0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Sun, 30 Jun 2019 07:14:35 GMT
server
nginx
etag
"91429c817978b489984fb6a33fe6c53a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
19328
expires
Mon, 14 Oct 2019 06:23:58 GMT
trispharmarecall3_1513143-1024x369.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
64 KB
65 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/trispharmarecall3_1513143-1024x369.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
dd0af35e3041167ac14093ee32b0670cf791f8cfe5d07fa03375800fc630acab
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Thu, 21 Mar 2019 01:51:20 GMT
server
nginx
etag
"80c0bab99151b066fdf5a250bec4edf5"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
65856
expires
Mon, 14 Oct 2019 06:23:58 GMT
483963asthmainhaleroverweig_955453.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
39 KB
39 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/483963asthmainhaleroverweig_955453.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c0500a8285a082f6a9c9536209ad0101e9f1dfcadd1bc2b2ad25e893c38caf9e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Thu, 21 Mar 2019 02:04:45 GMT
server
nginx
etag
"d966ee7760f65d7bb9283f300d21472b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
39469
expires
Mon, 14 Oct 2019 06:23:58 GMT
autismspectrumg478570600_1404783.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
30 KB
30 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/autismspectrumg478570600_1404783.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
916440c0da7c4574d8730c8440a886e3b2ecc69e9f9a04029db859c9c2e72b47
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 09:14:24 GMT
server
nginx
etag
"6306c081655e8ce2714c1322ce274645"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
30289
expires
Mon, 14 Oct 2019 06:23:58 GMT
nosecoldg730190641_1483978.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
22 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/nosecoldg730190641_1483978.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ce403d497f1e7f023f0fb7d9eb0b14acdfcb106d77b588325e720a3ec2af6023
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 19:50:30 GMT
server
nginx
etag
"5fa77d33767335426d35f12574541ce4"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
22391
expires
Mon, 14 Oct 2019 06:23:58 GMT
Vitamin-D-G-966728568.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/
15 KB
15 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/Vitamin-D-G-966728568.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a54d3bff6a0eee0fd36bfdb96e571636fca0fde8e8524daf3ea38fcbe3a834c8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Tue, 20 Aug 2019 07:11:10 GMT
server
nginx
etag
"d48c32930511e22f7ebc5af253ad08e7"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
15163
expires
Mon, 14 Oct 2019 06:23:58 GMT
Measles-Outbreak_G_1141748722-1024x683.jpg
www.empr.com/wp-content/uploads/sites/7/2019/07/
149 KB
150 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/07/Measles-Outbreak_G_1141748722-1024x683.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
89d66c95f1d1240afc45730342c0e469adda97e1a3b7a222bee31c7a742d5b81
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Sun, 28 Jul 2019 07:10:59 GMT
server
nginx
etag
"d3dad9bb6ef8d73adfea48ee39d2aafa"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
152862
expires
Mon, 14 Oct 2019 06:23:58 GMT
482549nursevaccinesyringe6_964495.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
71 KB
71 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/482549nursevaccinesyringe6_964495.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
5f257545df04ed07e6784beb338d6d60ec50ab52da4432de2a7276e37f8ed2af
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 19:38:05 GMT
server
nginx
etag
"71cb49e9fe6364f3fbc8edb242f72947"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
72251
expires
Mon, 14 Oct 2019 06:23:58 GMT
pregnantwomannl_295438.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
25 KB
25 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/pregnantwomannl_295438.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c28c0ab203200c698139f50a8fd95a68a0d08969336442bd297229b9cf86f11e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 19:56:33 GMT
server
nginx
etag
"c6024c2b663e2a839f01bc349dacb35e"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
25299
expires
Mon, 14 Oct 2019 06:23:58 GMT
activatedplateletsg17259295_1466249.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
22 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/activatedplateletsg17259295_1466249.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9d7f1238638cb9c3d4092a726046a39f5fbe62ee9b91df6c0e0741c31508302f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 21:56:03 GMT
server
nginx
etag
"6ee480cf359331bf7a75c880eff8af86"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
22623
expires
Mon, 14 Oct 2019 06:23:58 GMT
hepatitisbss531853195_1353359.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
28 KB
28 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hepatitisbss531853195_1353359.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
65f2cba11d7a8fb4e042413fdcc6fee12e8723c6ae51bf120b49d7a429178a2e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:54:35 GMT
server
nginx
etag
"cdc768ed36bc7cd647d98f86f71da777"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
28834
expires
Mon, 14 Oct 2019 06:23:58 GMT
addictionblackboardns_976459.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
208 KB
209 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/addictionblackboardns_976459.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
dd83fa49e982e970aacc414141424d05ade87f7b3019ebe34dbda158a48b3e05
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 23:40:35 GMT
server
nginx
etag
"5a2b9b7a2a54a291580b228f6f6b2673"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
213354
expires
Mon, 14 Oct 2019 06:23:58 GMT
orphandrugns_1001134.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
99 KB
99 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/orphandrugns_1001134.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
98a61fed7de6a5c75832311d91304c00452e1d6cd6f7a52c6caf2fe0ae5e6ae3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Thu, 21 Mar 2019 01:48:21 GMT
server
nginx
etag
"2a5dcea17f36dac1ec0834d867995982"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
100894
expires
Mon, 14 Oct 2019 06:23:58 GMT
inveltyspackagenskala_1520295.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
13 KB
13 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/inveltyspackagenskala_1520295.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
54.210.29.109 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-210-29-109.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7b9025bc821fe7e035dba945260d61e17a43699d25d06392182e81d0d565e455
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sat, 14 Sep 2019 06:23:58 GMT
last-modified
Wed, 20 Mar 2019 09:08:36 GMT
server
nginx
etag
"3f5e1c636a33868979996690f1b7b208"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
12912
expires
Mon, 14 Oct 2019 06:23:58 GMT
registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
ads
securepubads.g.doubleclick.net/gampad/
4 KB
2 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1812571608212860&correlator=2700692366325867&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21064571%2C21063203%2C21063966&vrg=2019090901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190914&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123844%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DGastrohepatic_Disorders%252CIrritable_Bowel_Syndrome%252CMiscellaneous_Gastrohepatic_Disorders%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_esketamine052018%252CHMN_Rexulti_2019%252Cmpr_basaglar042616%252CMPR_JanssenDermatology_2019%252Cmpr_latuda062017%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLM_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1568442238&dt=1568442238362&dlt=1568442236713&idt=587&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=3993&adk=1518026067&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x3993&msz=1585x1&ga_vid=58522034.1568442237&ga_sid=1568442238&ga_hid=2004929519&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
dfd149a4595976dd2c091f915652771ccf951b2fb11086551bbe3dd3f15d6ea6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1973
x-xss-protection
0
google-lineitem-id
132788185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138274708445
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019090901.js
securepubads.g.doubleclick.net/gpt/
62 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
sffe /
Resource Hash
f92613e18f86a27550aa6d749c835105da1adcb8144563d352341a871cf7e8ec
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 09 Sep 2019 13:07:13 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
24115
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:58 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0

universal-tag.js
ads.spotible.com/tag/ Frame 2546
4 KB
2 KB
Script
General
Full URL
https://ads.spotible.com/tag/universal-tag.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Content-Encoding
gzip
ETag
"5c736e518f66ceaaee6badc00016e1a5"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=3600
Connection
keep-alive
Content-Length
1767
truncated
/ Frame 2546
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
de430ae821647cace66ff1073626b25180dd0f511900060001b8a32520f43b2f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fa6c0d77f097497e1a53b31c22f0aac13947e9a7a72a5202806411bebf7c916a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568373336498356"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29135
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:58 GMT
ads
securepubads.g.doubleclick.net/gampad/
19 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1812571608212860&correlator=2700692366325867&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&eid=21064571%2C21063203%2C21063966&vrg=2019090901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190914&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123844%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DGastrohepatic_Disorders%252CIrritable_Bowel_Syndrome%252CMiscellaneous_Gastrohepatic_Disorders%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_esketamine052018%252CHMN_Rexulti_2019%252Cmpr_basaglar042616%252CMPR_JanssenDermatology_2019%252Cmpr_latuda062017%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLM_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3Def113f6eca2961ef%3AT%3D1568442238%3AS%3DALNI_MbC1evyfwLZtw3QNtV_lg3UKW43zA&cookie_enabled=1&bc=31&abxe=1&lmt=1568442239&dt=1568442239003&dlt=1568442236713&idt=587&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=2785330797&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&dssz=79&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&psts=Ci8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QIsvsAm2swrZA&ga_vid=58522034.1568442237&ga_sid=1568442238&ga_hid=2004929519&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
df67af7bca7f3f030738c95ac7ef6ff9edf82322924cd9830414bef052435434
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5699
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494044025
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
creative-delivery.js
ads.spotible.com/creative/bmMb/
58 KB
20 KB
Script
General
Full URL
https://ads.spotible.com/creative/bmMb/creative-delivery.js
Requested by
Host: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
2df541ba2dac12759f5cc36999736a318e366452d683593b713ca1a53d1e27e5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:58 GMT
Content-Encoding
gzip
ETag
"c1d949de721a6052e9634dc663595413"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
no-cache
Connection
keep-alive
Content-Length
19905
MPR-lightbox_640x480-july19_Q.gif
cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/
685 KB
686 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/MPR-lightbox_640x480-july19_Q.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.69 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-69.fra53.r.cloudfront.net
Software
/
Resource Hash
ad15e0951b55982ad0447c99a54cc497669f65c84ac6b12616891fec5f51223c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 11 Sep 2019 07:03:25 GMT
via
1.1 6080b2713e502211e152f21f5c59c5a7.cloudfront.net (CloudFront)
age
256834
etag
"a0bb68f349c5a16009bb7cf6d5bab3bb"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
701058
x-amz-cf-id
_nEeua4ajDQBzk46IcenU-xYu9VTy6L1FR8YhAhouhJnhcOhJyNVqg==
view
securepubads.g.doubleclick.net/pcs/ Frame 8337
0
48 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvpOGhnaN9_LpI505OMj1wIoba3YW3Pi7kjP8mki1VcyqIGoseqe71aVBZ2ZgW8BtoIth9-C0DSGFEt8j1zfm1IEe2rVv1ggdoeTymbwfNGWNRRo4GjLnw8h9o-YX7s5AQ7W67FgpOjlDYQn2FC_bRE6hOR_KJ1gGPzvhTWbfttGxE9j-XNO9QnqAOei9oILrMUpxuWBd7Hb2fUaTGlg5LxEK02p8BFEdzWsoNl3QQHhmWwI7En_1uODnltnF-rZVzfl5e4snvFdcTSswJEEZSdDg&sig=Cg0ArKJSzEc9MUqoQah7EAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:59 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/ Frame 8337
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 11 Sep 2019 20:13:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
209454
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 25 Sep 2019 20:13:05 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 8337
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5ae991940db5f8d052ab0ff33ec4be064db50ed1f3f649a4576af4687bff8d21
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568373336498356"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29635
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:59 GMT
l
www.google.com/ads/measurement/ Frame 8337
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQevO6MJB6tszkchnDQLs1ZIRh4zwDCSerY56U5Y5TuMBUL6nfczuZN4ZEL27nj6Ys-b3jbuQRtYcVXaWCwat5-EemWNA
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 8337
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776212071&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494044025&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
2a4c636636adb5c8bd590bc125a3a4830211e36adf111b88fd06052c1557c30d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
5536585125677552591
tpc.googlesyndication.com/simgad/ Frame 8337
68 KB
68 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/5536585125677552591
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
3a9b25967ee1a016b7bd6cff12850cfa623efc42ea5333d27fa71735eb476969
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Thu, 29 Aug 2019 06:09:16 GMT
x-content-type-options
nosniff
age
1383283
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
69914
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:46:42 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 28 Aug 2020 06:09:16 GMT
ads
securepubads.g.doubleclick.net/gampad/
19 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1812571608212860&correlator=2700692366325867&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&eid=21064571%2C21063203%2C21063966&vrg=2019090901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190914&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26lid%3D132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123844%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DGastrohepatic_Disorders%252CIrritable_Bowel_Syndrome%252CMiscellaneous_Gastrohepatic_Disorders%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_esketamine052018%252CHMN_Rexulti_2019%252Cmpr_basaglar042616%252CMPR_JanssenDermatology_2019%252Cmpr_latuda062017%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLM_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3Def113f6eca2961ef%3AT%3D1568442238%3AS%3DALNI_MbC1evyfwLZtw3QNtV_lg3UKW43zA&cookie_enabled=1&bc=31&abxe=1&lmt=1568442239&dt=1568442239183&dlt=1568442236713&idt=587&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=204078694&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&dssz=79&icsg=152282360446980&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&psts=Ci8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QIsvsAm2swrZA%2CCi8IobmoP-gB-ZbY_LEDggIVsbmAD9G59iGBw_Yh8e3PNOfA2o9R0QJ-wSB-iLvnKQ&ga_vid=58522034.1568442237&ga_sid=1568442238&ga_hid=2004929519&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
8633e790f1c142318cd4998294ab19a774c3a8eddd798f037de2e0695cf697bb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5467
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494027705
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 8337
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8ba5dbba5d3bba25ff0e94e24c86b193112f65017d20dec9cdd8d5b40c3cdebc

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
365 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:7000:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 7fcb41b117930690c299be9cec4a977a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
af2219e9-0eab-4d32-b54a-a4f214fa7c6e
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d7c877f-cdf4e2cdbac311abf38f4638;Sampled=0
x-amz-apigw-id
f_ob7FYyIAMF-bw=
content-length
2
x-amz-cf-id
Rlf_Rf23Vu9YWDTrQwyhhdml_EE6Xd9P6xORY4a9BkYryAxG2eIbfw==
view
securepubads.g.doubleclick.net/pcs/ Frame 3CC1
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvHO2U8xb4UWDLTSp427wkMb4ZlBQlb2x5Zv_DNgk6iZo6qg6sskFF97FlD5glbjIwJbEGOlFL5gwbIx-o6JH5AzhLiW0oYWze2qo8nXMlHeAr26cR27jsdPGDClcNTy2QcmjQuqDjFySAkprSzChTxvGIF2pVzmVk9C9aHT1Pz7IiKtnhmZ7KzU6cStg36t311a03X017aVudTJyH-TMV3YMrVSDWawUL9GP1En1lUCtzsqFhMic7ZmZeKZVubHnPA4R4RAZGR&sig=Cg0ArKJSzDAX_DZFAcpCEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:59 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/ Frame 3CC1
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 11 Sep 2019 20:13:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
209454
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 25 Sep 2019 20:13:05 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 3CC1
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5ae991940db5f8d052ab0ff33ec4be064db50ed1f3f649a4576af4687bff8d21
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568373336498356"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29635
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:59 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 3CC1
13 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031401&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494027705&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
904f4c933769eea8b21544c0ea3bc0d626ffb2fe0a92cc7301140bd4d6d77646

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
8299312168136675521
tpc.googlesyndication.com/simgad/ Frame 3CC1
90 KB
90 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/8299312168136675521
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
e98ee80eff9057ec97269e5a00f640221bbdb5cbfbeebc82e09034cd36c32fb0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 23:35:10 GMT
x-content-type-options
nosniff
age
888529
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
92358
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:20:51 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 02 Sep 2020 23:35:10 GMT
gen_204
pagead2.googlesyndication.com/pagead/
0
58 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gpt_sz&r=300x250%7C300x600&w=300&h=600
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
19 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1812571608212860&correlator=2700692366325867&output=ldjh&callback=googletag.impl.pubads.callbackProxy4&impl=fif&adsid=NT&eid=21064571%2C21063203%2C21063966&vrg=2019090901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190914&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26lid%3D132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123844%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DGastrohepatic_Disorders%252CIrritable_Bowel_Syndrome%252CMiscellaneous_Gastrohepatic_Disorders%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_esketamine052018%252CHMN_Rexulti_2019%252Cmpr_basaglar042616%252CMPR_JanssenDermatology_2019%252Cmpr_latuda062017%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLM_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3Def113f6eca2961ef%3AT%3D1568442238%3AS%3DALNI_MbC1evyfwLZtw3QNtV_lg3UKW43zA&cookie_enabled=1&bc=31&abxe=1&lmt=1568442239&dt=1568442239347&dlt=1568442236713&idt=587&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=1176&adk=3917873969&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&dssz=79&icsg=152282360446980&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&psts=Ci8IobmoP-gBuZfX_LEDggIVsbmAD9G59iGBw_Yh8e3PNKm9z49R0QIJxb990T5L-A%2CCi8I2d-oP-gB3bfCjoMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QIsvsAm2swrZA%2CCi8IobmoP-gB-ZbY_LEDggIVsbmAD9G59iGBw_Yh8e3PNOfA2o9R0QJ-wSB-iLvnKQ&ga_vid=58522034.1568442237&ga_sid=1568442238&ga_hid=2004929519&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
3c64eec268023fa067f5c4212e600d013fd36e6051a76fb7251f04834e82a909
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5504
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274593
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ad.gif
api-54-149-252-201.b2c.com/api/ Frame 8337
43 B
233 B
Image
General
Full URL
https://api-54-149-252-201.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:4e1e:206:eb19:a1c3 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
truncated
/ Frame 3CC1
219 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
faeaca4dfc14c9fd55335539e96839016efc8b158818e26e3b7d8a5dee58cb14

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
367 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:7000:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
via
1.1 7fcb41b117930690c299be9cec4a977a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
549d3d28-1a90-4dad-9ec3-54f49eb0bdf9
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d7c877f-5b0e0b48df44d4606b0dce50;Sampled=0
x-amz-apigw-id
f_ob8GLSIAMF5sg=
content-length
2
x-amz-cf-id
f--HVhfvD9F6SDxQNYUulMqBuWuoJSGN3RKpg67Q43Q9d-t9bzVVZw==
view
securepubads.g.doubleclick.net/pcs/ Frame 8487
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvdpQkExDme5w7_GC2NJ6jKoX4mZJgLWKo72YRslOeT6XNVuKNDsiZbxcQDCb8cwG9XTAGeIpmD1gqBRhx7Y1lFY3KFkj0aI9lhmBulFrbXTdM6Z9skz_8Gu4qxY9oJhqv2IIk4_QsLwdmpAOSVGBkypTC-vTZQjmEctykkxbpg67kVLfQDKT2v5jAwB5SyWIgrQibrBmF0eYOlJfqpAW5jv-Awb6DC1vhUn4FBZG8CR0CT1BHitOMvQtQmSlGlnL7iqfg7wqMitA&sig=Cg0ArKJSzL_EtjBB44iYEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:59 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/ Frame 8487
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190911/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 11 Sep 2019 20:13:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
209454
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 25 Sep 2019 20:13:05 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 8487
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5ae991940db5f8d052ab0ff33ec4be064db50ed1f3f649a4576af4687bff8d21
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1568373336498356"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
29635
x-xss-protection
0
expires
Sat, 14 Sep 2019 06:23:59 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 8487
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031404&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274593&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
eb36c0210c38cac08ff7f8ce5a0179680be14fc5781ae7b9576ae139a540c9d5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:23:59 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
4489233149016687223
tpc.googlesyndication.com/simgad/ Frame 8487
41 KB
41 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/4489233149016687223
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019090901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 16:55:29 GMT
x-content-type-options
nosniff
age
912510
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42317
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:46 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 02 Sep 2020 16:55:29 GMT
ad.gif
api-54-213-250-89.b2c.com/api/ Frame 3CC1
43 B
233 B
Image
General
Full URL
https://api-54-213-250-89.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1b8a:31e5:73b3:40e8 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
truncated
/ Frame 8487
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e69952e4afd3d9bf69c8cd4b84b0822ab25371e241d2b35712d420bef9f1b26b

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:7000:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sat, 14 Sep 2019 06:24:00 GMT
via
1.1 7fcb41b117930690c299be9cec4a977a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
622775d1-1d73-4167-a748-c05bd374a1a6
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d7c8780-5497e90c37b5a78a53bf114e;Sampled=0
x-amz-apigw-id
f_ocCHLrIAMF_nw=
content-length
2
x-amz-cf-id
ShoyjEn1zT-4DfYV1JYwDgH2vIcs1G2rexBgvEZQEgSlhTU-yrdVAw==
report
ads.spotible.com/creative/bmMb/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/bmMb/report?,1568442239,556001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!2,1,0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
57 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssW0r781J2L5nVOB0_MtcAVPOBT6dHIUGa_NwDbRrqvBDgsGtpaaqnSYXiVL-tuOFFuqnM5F1kB0AjGJRqrKvn2avihmOT_qY9itOMfFXY8L4HKkOfp1-JoKJR99IKO5JzsghQj9v8Z0ZfNga6cGfXAGMvAbba9ScGwKvTRDsSAM5bI9zolnhPVddzy5OHtTr71X6XY2XafhSfvU4Cays9FzZHuMOyiPiOi2Ku4D1nZj4olbGtib5Xr4eX6rawyxD8rqMbi1uzI73LgR5cZSWMu6IYUhH78ymQjW31mF5FvfPK5_9j8Cs5BifX2Uw&sai=AMfl-YRASe4oMsjyp7XBCjjG19IcJKzszDF4K1-7I1H5DoFCnv1Hn02CoZ4HQW2FG4Kvc2_GO3j4aWinyrcS24_VLYA2PdS48OXVN2gTf5UnhQ&sig=Cg0ArKJSzATWoF1GwcfKEAE&urlfix=1&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sat, 14 Sep 2019 06:23:59 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
ad.gif
api-54-149-252-201.b2c.com/api/ Frame 8487
43 B
233 B
Image
General
Full URL
https://api-54-149-252-201.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:4e1e:206:eb19:a1c3 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-149-252-201.b2c.com/api/ Frame 8337
Redirect Chain
  • https://api-54-149-252-201.b2c.com/api/x?FZj5pTlzOvZhNeOl$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR...
  • https://api-54-149-252-201.b2c.com:444/api/4?FZj5pTlzOvZhNeOl
43 B
441 B
XHR
General
Full URL
https://api-54-149-252-201.b2c.com:444/api/4?FZj5pTlzOvZhNeOl
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.149.252.201 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-149-252-201.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:24:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Server
openresty
Location
https://api-54-149-252-201.b2c.com:444/api/4?FZj5pTlzOvZhNeOl
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:7000:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sat, 14 Sep 2019 06:24:00 GMT
via
1.1 7fcb41b117930690c299be9cec4a977a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
1be3972f-6352-4bf7-bf6d-1af95a9cbe24
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d7c8780-780be4d4c2bc4cf434b28d70;Sampled=0
x-amz-apigw-id
f_ocDEPDoAMF1nA=
content-length
2
x-amz-cf-id
vSU5Ub-o_RFJcDLv6NVzd5F4Kjp7FG1aI4E8oZve4g0zxoEhM3mlOw==
4
api-54-213-250-89.b2c.com/api/ Frame 3CC1
Redirect Chain
  • https://api-54-213-250-89.b2c.com/api/x?TNbUIlIUWQRTOUJ5$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR0...
  • https://api-54-213-250-89.b2c.com:444/api/4?TNbUIlIUWQRTOUJ5
43 B
441 B
XHR
General
Full URL
https://api-54-213-250-89.b2c.com:444/api/4?TNbUIlIUWQRTOUJ5
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.213.250.89 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-213-250-89.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:24:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sat, 14 Sep 2019 06:23:59 GMT
Server
openresty
Location
https://api-54-213-250-89.b2c.com:444/api/4?TNbUIlIUWQRTOUJ5
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-54-149-252-201.b2c.com/api/ Frame 8487
Redirect Chain
  • https://api-54-149-252-201.b2c.com/api/x?d0sNdPVHaHy5lyNs$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR...
  • https://api-54-149-252-201.b2c.com:444/api/4?d0sNdPVHaHy5lyNs
43 B
441 B
XHR
General
Full URL
https://api-54-149-252-201.b2c.com:444/api/4?d0sNdPVHaHy5lyNs
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.149.252.201 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-149-252-201.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:24:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sat, 14 Sep 2019 06:24:00 GMT
Server
openresty
Location
https://api-54-149-252-201.b2c.com:444/api/4?d0sNdPVHaHy5lyNs
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
Cookie set rt=ifr
bcp.crwdcntrl.net/5/c=14413/rand=444215595/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%2... Frame C71C
0
0
Document
General
Full URL
https://bcp.crwdcntrl.net/5/c=14413/rand=444215595/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20fda-approves-first-in-class-treatment-for-ibs-c/med=%23OpR%2397539%23Article%20Tags%20%3A%20Gastrohepatic%20Disorders%2CIrritable%20Bowel%20Syndrome%2CMiscellaneous%20Gastrohepatic%20Disorders/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.194.238.142 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-194-238-142.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Accept-Encoding
gzip, deflate, br
Cookie
_cc_dc=1; _cc_id=a3d94424705bcb1ee6cc1edac1019145; _cc_cc="ACZ4nGNQSDROsTQxMTIxNzBNSk4yTE01S042TE1JTDY0MLQ0NDFlAILYmvZaBgQAAFuICto%3D"; _cc_aud="ABR4nGNgYGCIrWmvZYADABcnAd4%3D"
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Sat, 14 Sep 2019 06:24:00 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_id=a3d94424705bcb1ee6cc1edac1019145;Path=/;Domain=crwdcntrl.net;Expires=Wed, 10-Jun-2020 06:06:00 GMT;SameSite=None _cc_cc="ACZ4nGNQSDROsTQxMTIxNzBNSk4yTE01S042TE1JTDY0MLQ0NDFlAILYmvaGv%2F%2F%2F%2F%2BdngAGe6zNbFBnPFjD8Z2Rk6J2OYN98chXOPjUZIT79hDqM%2BWBqDyOM%2FfGzJYx5%2BfkdWRj78OI5LDD2BST2pVOP2GDs%2FcuPwtUDAPQbQ7Y%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Wed, 10-Jun-2020 06:06:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCIrWlvYIABJgaOK7UgBsftQ0ASAEjqBOE%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Wed, 10-Jun-2020 06:06:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.1.85
Content-Length
715
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:24:00 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Tue, 17 Sep 2019 06:24:00 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
fd9777ddf127f9be5789d253d894447768d4693a149d89660ec13746a205c1d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:24:00 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
up
insight.adsrvr.org/track/ Frame B683
0
0
Document
General
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&upid=7fhq4wn&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.76.69.10 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-76-69-10.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&upid=7fhq4wn&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933

Response headers

status
503
date
Sat, 14 Sep 2019 06:24:08 GMT
content-type
text/html
content-length
27
cache-control
no-cache, must-revalidate
pragma
no-cache
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
collect
www.google-analytics.com/
35 B
99 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=2004929519&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&ul=en-us&de=UTF-8&dt=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGDAAAAjQ~&jid=&gjid=&cid=58522034.1568442237&tid=UA-1290429-2&_gid=50566382.1568442237&gtm=2wg9415XFK9V6&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_unknown&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(67%20segments%20found)&z=1206842517
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 29 Aug 2019 03:29:33 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1392867
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/
35 B
93 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=2004929519&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&ul=en-us&de=UTF-8&dt=FDA%20Approves%20First-in-Class%20Treatment%20for%20IBS-C%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F&el=25%25&ev=25&_u=aGDAAAAjQ~&jid=&gjid=&cid=58522034.1568442237&tid=UA-1290429-2&_gid=50566382.1568442237&gtm=2wg9415XFK9V6&z=997076261
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 29 Aug 2019 03:29:33 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1392867
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
x
api-54-213-250-89.b2c.com/api/ Frame 3CC1
0
382 B
Other
General
Full URL
https://api-54-213-250-89.b2c.com/api/x?TNbUIlIUWQRTOUJ5$YWRibG9jayQ1MjYkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1b8a:31e5:73b3:40e8 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:24:00 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
ad.gif
api-54-213-66-127.b2c.com/api/
43 B
233 B
Image
General
Full URL
https://api-54-213-66-127.b2c.com/api/ad.gif
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1641:e747:2346:4835 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:24:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
activeview
pagead2.googlesyndication.com/pcs/ Frame 8337
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssyB7qDNXkcXoTPiimi3ohIFBsdzU2d0qni5HaV6nrSEiA06fYUcag-jQuXTxcHsHTfhNfP9u8JeevYpDuHzjEwbVEOKhuK_vv5N2m63Cc&sig=Cg0ArKJSzAfZQcGd2tzyEAE&adk=2785330797&tt=-1&bs=1585%2C1200&mtos=1080,1080,1080,1080,1080&tos=1080,0,0,0,0&p=140,429,230,1157&cm=1&mcvt=1080&rs=0&ht=0&tfs=156&tls=1236&mc=1&lte=1&bas=0&bac=0&met=1&avms=nio&exg=1&md=2&lm=2&rst=1568442239178&dlt=0&rpt=34&isd=0&msd=0&xdi=0&ps=1585%2C4083&ss=1600%2C1200&pt=-1&bin=4&deb=1-0-0-8-12-5-11-11-0-0-0&tvt=1233&is=728%2C90&iframe_loc=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Ffda-approves-first-in-class-treatment-for-ibs-c%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190914%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-68057-5059933&r=v&id=osdim&vs=4&uc=12&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190913
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:24:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 3CC1
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstwBP91vY2irxXQB2-hCBuCgJNxpZ2K3VNo3pEs158XTD2TLzLwCgbcxt8ZQCRRZlxXIelKMZ9zogrymkpOeKMd6_odQ0mexHUPyy9HeVQ&sig=Cg0ArKJSzE5kUYnTQ9fJEAE&adk=204078694&tt=354&bs=1585%2C1200&mtos=1068,1068,1068,1068,1068&tos=1068,0,0,0,0&p=305,1053,905,1353&mcvt=1068&rs=3&ht=0&tfs=490&tls=1558&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=355&niot_cbk=382&md=2&lm=2&rst=1568442239334&rpt=136&isd=0&msd=0&phel=1&phell=1&oseid=3&xdi=0&ps=1585%2C4083&ss=1600%2C1200&pt=1206&bin=1&deb=1-1-4-23-15-12-59-14-0-0-0&tvt=1551&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x600&itpl=3&v=20190913
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sat, 14 Sep 2019 06:24:00 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
4
api-54-213-66-127.b2c.com/api/
Redirect Chain
  • https://api-54-213-66-127.b2c.com/api/x?rMOqFXO7f2NITgHD$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2ZkYS1hcHByb3Zlcy1maXJzdC1pbi1jbGFzcy10cmVhdG1lbnQtZm9yLWlicy1jLz91dG1fc291cmNlPW5ld3NsZXR0...
  • https://api-54-213-66-127.b2c.com:444/api/4?rMOqFXO7f2NITgHD
43 B
441 B
XHR
General
Full URL
https://api-54-213-66-127.b2c.com:444/api/4?rMOqFXO7f2NITgHD
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.213.66.127 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-213-66-127.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sat, 14 Sep 2019 06:24:00 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sat, 14 Sep 2019 06:24:00 GMT
Server
openresty
Location
https://api-54-213-66-127.b2c.com:444/api/4?rMOqFXO7f2NITgHD
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
close_button2.png
cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/
1 KB
2 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/close_button2.png
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.69 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-69.fra53.r.cloudfront.net
Software
/
Resource Hash
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 13 Sep 2019 09:07:39 GMT
via
1.1 6080b2713e502211e152f21f5c59c5a7.cloudfront.net (CloudFront)
age
76583
etag
"74483a4bff0849849588dbf32a396fe9"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
1429
x-amz-cf-id
YNslFF7zU3R_g1Lfs-FUh_iSzaBefLRPDRFn1EobZr9M24VUjJfCBw==
report
ads.spotible.com/creative/bmMb/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/bmMb/report?,1568442239,556003;IMPRESSION!4,1,0!5,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/fda-approves-first-in-class-treatment-for-ibs-c/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190914&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLM_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-68057-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 14 Sep 2019 06:24:03 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html

Verdicts & Comments Add Verdict or Comment

199 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14413 object| LOTCC object| Digest function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents string| redirect object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store object| epas function| maropostInitTracking string| name_funnel function| _132350 string| name_funnel1 function| _13235 object| data object| ids undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id object| epasAPI object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData object| adblockDetector object| pageVars object| wp function| hmOpenRegisterPrompt function| webpackJsonp object| _atrk_opts function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode object| google_optimize object| AIM object| _ml function| __jstag_onload undefined| initObj string| ly_cid function| atrk boolean| _atrk_fired object| ns_ string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit object| _0x2d25 function| _0x4017 object| lio function| ttd_dom_ready function| TTDUniversalPixelApi object| optimizely object| pathfora function| HMIRegistration object| ssoLogin object| ssoRegister number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| prontoTags object| ProntoCE object| ProntoDOMEvents object| google_image_requests object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

39 Cookies

Domain/Path Name / Value
www.medtargetsystem.com/ Name: DMDSESSID
Value: 8svgqklmositcabbt3nq8no9c1
www.empr.com/ Name: PathforaTest_eba13817e4cda2f9087c77f4803500dc
Value: 0.577729978275414
www.empr.com/ Name: PathforaTest_d32aacecfe87458780ba0a5b22e84019
Value: 0.7039013229732176
www.empr.com/ Name: PathforaTest_853e3ee5e01881b83ab49fe8c2eae359
Value: 0.524592720910656
www.empr.com/ Name: PathforaTest_845520b7c2ad6c7b2d753bf3b76b1546
Value: 0.6478657874964326
www.empr.com/ Name: PathforaTest_6bc045766412f0ca499172958fc3e795
Value: 0.5686465741949014
www.empr.com/ Name: PathforaTest_354ff931e1d1ba292afc8446d8447661
Value: 0.0818988183191478
www.empr.com/ Name: PathforaTest_fbcdd6902623329bbdbacbed41b3575a
Value: 0.7538856152283
www.empr.com/ Name: PathforaTest_16c648a7e9a8e384a49983317da2418c
Value: 0.7153342688494051
.empr.com/ Name: __gads
Value: ID=ef113f6eca2961ef:T=1568442238:S=ALNI_MbC1evyfwLZtw3QNtV_lg3UKW43zA
www.empr.com/ Name: dmd-d6fc1a03-6508-42be-86c5-d9c0199b0ed7
Value: e30=
www.empr.com/ Name: _sess
Value: d6fc1a03-6508-42be-86c5-d9c0199b0ed7.8e584310-f79e-4efc-93f7-bb3e06abfb50.1568442237.2
www.empr.com/ Name: PathforaPageView
Value: 1
www.empr.com/ Name: _ccmaid
Value: 5978151497268606219
.www.empr.com/ Name: seerid
Value: 2212176f3b05219f5a6d9fdd8a356e86
www.empr.com/ Name: dmd-ahk
Value: 6a8850381f
.empr.com/ Name: seerid
Value: 2212176f3b05219f5a6d9fdd8a356e86
www.empr.com/ Name: register-pages
Value: 1
.empr.com/ Name: _maro_account_id
Value: BAhpAisF--37e0a5dc91bbd179df584d1ded7f2656371a9960
www.empr.com/ Name: PathforaTest_2c3134d8bbcf5fc7ef88d4f188d3d27a
Value: 0.7147057853882341
www.empr.com/ Name: dmd-sid
Value: d6fc1a03-6508-42be-86c5-d9c0199b0ed7
www.empr.com/ Name: hmSsoCheck
Value: true
.www.empr.com/ Name: seerses
Value: e
.empr.com/ Name: seerses
Value: e
.empr.com/ Name: _maro_campaign_id
Value: BAhpA9kJAQ==--edf5d9c54d405c6d4727aaea4ce65713ef8bfbfd
www.empr.com/ Name: _ccmsi
Value: 1568442237384_n7xdyue88|1568442237384
.empr.com/ Name: _gat_UA-1290429-2
Value: 1
www.empr.com/ Name: hmNpiId
Value: 1518074491
.empr.com/ Name: __asc
Value: 1101a0c016d2e7141b5fc8b3562
.empr.com/ Name: _maro_contact_id
Value: BAhpA101TQ==--9cd672c348552200f873f09fa8840e8d9f29f654
.empr.com/ Name: __auc
Value: 1101a0c016d2e7141b5fc8b3562
www.empr.com/ Name: PathforaTest_c835c8fce5cb8c9ae765bcc82e287892
Value: 0.46330014851260426
.empr.com/ Name: _fbp
Value: fb.1.1568442237408.1352123813
.empr.com/ Name: _gid
Value: GA1.2.50566382.1568442237
.empr.com/ Name: _ga
Value: GA1.2.58522034.1568442237
www.empr.com/ Name: spinfo
Value: spem=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0
www.empr.com/ Name: PathforaTest_00a2fe23f73e4b2dcdcaba9058b0c8da
Value: 0.6663558483610468
www.empr.com/ Name: dmd-vid
Value: 8e584310-f79e-4efc-93f7-bb3e06abfb50
www.empr.com/ Name: adcpn2
Value: im_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLM_Aug28DH

77 Console Messages

Source Level URL
Text
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 6)
Message:
checkForCPNSegments(ddw_opened_to_all)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_unknown_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_unknown
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-54-149-252-201.b2c.com
api-54-213-250-89.b2c.com
api-54-213-66-127.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn1.spotible.com
certify.alexametrics.com
connect.facebook.net
content.maropost.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
tpc.googlesyndication.com
104.108.34.58
13.32.220.201
13.35.253.107
13.35.253.71
143.204.214.69
18.200.54.67
18.213.112.55
2.21.37.45
216.58.210.2
23.43.115.95
2600:1f14:e96:5800:1641:e747:2346:4835
2600:1f14:e96:5800:1b8a:31e5:73b3:40e8
2600:1f14:e96:5800:3282:b5ef:e766:4370
2600:1f14:e96:5802:4e1e:206:eb19:a1c3
2600:9000:2057:7000:16:bc48:4dc0:93a1
2600:9000:2057:ae00:1b:fadc:b780:93a1
2606:4700:20::6819:5465
2606:4700::6813:9308
2a00:1450:4001:806::2002
2a00:1450:4001:815::2002
2a00:1450:4001:819::2008
2a00:1450:4001:819::200e
2a00:1450:4001:81c::2004
2a00:1450:4001:81d::2003
2a00:1450:4001:81e::2003
2a00:1450:4001:81f::200a
2a00:1450:4001:821::2002
2a00:1450:4001:825::2001
2a00:1450:400c:c06::9d
2a03:2880:f02d:12:face:b00c:0:3
2a03:2880:f12d:83:face:b00c:0:25de
3.120.224.89
3.209.234.104
34.197.62.58
34.225.65.223
34.233.109.111
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.206.48.92
52.216.138.157
52.3.171.116
52.31.106.135
54.149.252.201
54.194.238.142
54.210.29.109
54.213.250.89
54.213.66.127
54.76.69.10
93.184.220.113
94.31.29.64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